Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_assertion description "[Over the last few years, excitement over this class of agents has escalated due to reported activity as single agent in BRCA1- or BRCA2-associated ovarian or breast cancers, and in combination with chemotherapy in triple negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_assertion evidence source_evidence_literature NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_assertion SIO_000772 21718592 NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_assertion wasDerivedFrom befree-20150227 NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_assertion wasGeneratedBy ECO_0000203 NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP273772.RAaXMKHvO12-3Xohyx9_vvG3mOWKW4DkCibtAOZLDmfXM130_provenance.